This page houses the business plan for Innovative Potential.

​​

You will need to accept the following three (3) operational contexts before proceeding to the business plan:
 

1. Legally: Innovative Potential behaves closest to an international treaty or independent state corporation regarding: electrochemically activated chemotherapy (EAC), intratumor injection (ITI), the chemotherapeutic galvanostat/potentiostat (CGP), and or any derivative processes and products therein. Your public rights regarding EAC, ITI, the CGP and or any other ancillary products or processes therein, are already regulated through either the Canadian, the United States, or an other internationally recognized regulating body; and,
    

2. Internet: Innovative Potential is a biomedical first-principles entity. Innovative Potential exists unilaterally and ubiquitiously everywhere first-and-foremost with respect to the chemotherapeutic galvanostat/potentiostat via the supporting mechanisms and patents found in (1); and,
    

3. Financially: Because of the plethora of planetary-firsts derived from Innovative Potential and its technologies: it is fundamentally incorrect to apply or use a revenue-based business model to Innovative Potential: Innovative Potential is a top-down value-model asset-based entity. Innovative Potential makes concepts and technologies real, then considers run-of-the-mill trade (i.e., revenue). Innovative Potential scales in-favor of Jordache Boudreau, and itself, instantaneously World-wide for everything that it does, and that's value-add globalized economics, not supply-and-demand revenues. You're running your Empire wrong, again.
   ​

Additionally: Innovative Potential is:
 

• An internationally recognized and entreatied company via the Patent Cooperation Treaty; and,
   

• A federally-recognized and legal monopoly of Canada and the United States of America; and,
   

• Granted patented and exclusivized market powers from: 2017-2038, in both Canada and the United States of America; and,
   

• Internationally cross-licensed through a set of exclusive licensing agreements for the sharing and proliferation of intellectual property, including patents; and,
   

• The Problem is actually and legally: You.